Dendritic cell-based immunotherapy for prostate cancer

Citation
Ba. Tjoa et al., Dendritic cell-based immunotherapy for prostate cancer, CA-A CANC J, 49(2), 1999, pp. 117
Citations number
39
Categorie Soggetti
Oncology
Journal title
CA-A CANCER JOURNAL FOR CLINICIANS
ISSN journal
00079235 → ACNP
Volume
49
Issue
2
Year of publication
1999
Database
ISI
SICI code
0007-9235(199903/04)49:2<117:DCIFPC>2.0.ZU;2-H
Abstract
Dendritic cells are unique in their ability to stimulate naive T cells. The se investigators have developed a prostate cancer vaccine using autologous dendritic cells as a vehicle to present prostate antigens to T cells in viv o.